<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJAnes</journal-id><journal-title-group><journal-title>Open Journal of Anesthesiology</journal-title></journal-title-group><issn pub-type="epub">2164-5531</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojanes.2016.64008</article-id><article-id pub-id-type="publisher-id">OJAnes-65375</article-id><article-categories><subj-group subj-group-type="heading"><subject>Short Report</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Suspected Anaphylactic Shock Associated with Rocuronium in an Infant: A Case Report
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>ideya</surname><given-names>Katoh</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Yoshifumi</surname><given-names>Naito</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Chihiro</surname><given-names>Aoki</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mao</surname><given-names>Kinoshita</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Yoshinobu</surname><given-names>Nakayama</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Teiji</surname><given-names>Sawa</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Department of Anesthesiology, Kyoto Prefectural University of Medicine, Kyoto, Japan</addr-line></aff><author-notes><corresp id="cor1">* E-mail:<email>anesth@koto.kpu-m.ac.jp(TS)</email>;</corresp></author-notes><pub-date pub-type="epub"><day>08</day><month>04</month><year>2016</year></pub-date><volume>06</volume><issue>04</issue><fpage>51</fpage><lpage>54</lpage><history><date date-type="received"><day>3</day>	<month>March</month>	<year>2016</year></date><date date-type="rev-recd"><day>accepted</day>	<month>5</month>	<year>April</year>	</date><date date-type="accepted"><day>8</day>	<month>April</month>	<year>2016</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  We report a case of severe anaphylactic shock in a 5-month-old infant who was scheduled to undergo an external inguinal hernia repair under general anesthesia. Rocuronium used for anesthesia induction was the most likely cause of anaphylaxis. High levels of serum tryptase and histamine detected in the blood sample collected during the anaphylactic reaction confirmed the diagnosis of anaphylactic shock. The patient’s clinical status improved within 90 min of intervention by the intravenous injection of vasopressors and a steroid. Surgery was canceled, and the patient stayed in the pediatric intensive care unit (PICU) under artificial ventilation for 5 h before safe extubation. The patient achieved full recovery the next day, without any sequelae. The rescheduled surgery was successfully completed 5 months later under general anesthesia without the use of neuromuscular blocking agents.
 
</p></abstract><kwd-group><kwd>Anaphylaxis</kwd><kwd> Neuromuscular Blocking Agent</kwd><kwd> Rocuronium</kwd><kwd> Shock</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>The reported incidence of perioperative anaphylaxis ranges between 1:3500 and 1:20,000, with a mortality rate of 3.4% [<xref ref-type="bibr" rid="scirp.65375-ref1">1</xref>] . Although any medication can potentially cause perioperative anaphylaxis, neuromuscular blocking agents (NMBAs) are the most common cause, with 58.2% of all cases [<xref ref-type="bibr" rid="scirp.65375-ref2">2</xref>] and an overall incidence of 1:6500 in those receiving NMBAs [<xref ref-type="bibr" rid="scirp.65375-ref3">3</xref>] . In this report, we present a case of suspected anaphylactic shock associated with rocuronium in anesthesia induction of an infant who was planned to undergo external inguinal herniation surgery.</p></sec><sec id="s2"><title>2. Case Description</title><p>A 5-month-old, 7.1 kg male infant was scheduled for an external inguinal hernia repair under general anesthesia. Anesthesia was induced using the slow induction method, with the inhalation of a mixture of oxygen, nitrous oxide, and 2.5% sevoflurane, as well as subsequent intravenous injections of atropine sulfate (0.1 mg) and rocuronium (7.5 mg). Anesthesia was maintained under controlled ventilation using a mixture of air, oxygen, and 2% sevoflurane, with a small dose of intravenous fentanyl (5 &#181;g). Approximately 3 min after tracheal intubation, erythema, facial edema, tachycardia, and hypotension were observed, and manual ventilation suddenly became very difficult. The patient’s transdermal systolic blood pressure decreased to 40 mmHg (<xref ref-type="fig" rid="fig1">Figure 1</xref>).</p><p>The treatment for anaphylactic shock was immediately initiated with intravenous bolus injections of phenylephrine (0.01 mg) given six times, followed by ephedrine (0.4 mg) bolus injections given three times. His blood pressure gradually increased to 100/50 mmHg. Emergency invasive blood pressure measurement from the radial artery was established, and the scheduled surgery was cancelled. Methylprednisolone (50 mg) was also administered. After approximately1 h of observation in the operating room, the patient was transferred to the pediatric intensive care unit (PICU) under artificial ventilation, with intravenous midazolam for sedation. The patient was administered antihistaminic drugs and sedated with a continuous intravenous infusion of midazolam and dexmedetomidine in the PICU. His vitals became stable during the next 5 h, and he was safely extubated after no evidence of laryngeal edema was found by laryngoscopy. The next morning, he was transferred to the general pediatric ward and was discharged on the fifth day after the anaphylactic shock.</p><p>Subsequently, serum tryptase, histamine, and non-specific immunoglobulin (Ig)E levels in the blood sample collected 1 h after the shock were measured. Serum tryptase and histamine levels were high at 15.8 μg/L (normal, &lt;8 μg/L) and 1.95 ng/ml (0.15 - 1.23 ng/mL), respectively; however, the non-specific IgE level was within normal limits at 102 IU/mL. Two months after discharge, allergen tests performed by the pediatric department</p><fig id="fig1"  position="float"><label><xref ref-type="fig" rid="fig1">Figure 1</xref></label><caption><title> Record of the general anesthesia performed on a 5-month-old infant demonstrating anaphylactic shock during anesthesia induction. X, start and end of anesthesia; T, intubation</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/1-1920398x7.png"/></fig><p>detected many food sources, including milk, wheat, rice, egg yolk, egg white, and ovomucoid, as allergens in this patient.</p><p>Five months after the anaphylactic shock, the external inguinal hernia repair was performed. Before anesthesia, a route for intravenous injections was established at the pediatric ward while the patient was awake. In the operating room, after the intravenous injection of atropine sulfate, general anesthesia was induced with the inhalation of a mixture of nitrous oxide, oxygen, and 5% sevoflurane, and suxamethonium chloride for laryngospasm was prepared for emergency use. After sufficient anesthesia was achieved with inhalation by mask ventilation, a supraglottic airway device (Laryngeal Mask Proseal<sup>TM</sup>; size, 1.5) was inserted through the oral cavity with no use of muscle relaxants or narcotics. Anesthesia with spontaneous respiration was maintained under the continuous inhalation of a mixture of nitrous oxide, oxygen, and 2.5% - 3.0% sevoflurane. Surgery was completed without complications. The patient was extubated in the operating room after recovery from anesthesia with no problems and was discharged the next day.</p></sec><sec id="s3"><title>3. Discussion</title><p>Several epidemiological studies and case reports about rocuronium and anaphylaxis have been reported up until today [<xref ref-type="bibr" rid="scirp.65375-ref4">4</xref>] - [<xref ref-type="bibr" rid="scirp.65375-ref7">7</xref>] . However, rocuronium-induced anaphylaxis in infants must be very rare because we cannot easily find it in the public databases. Based on the high levels of serum tryptase and histamine, this patient was later confirmed to have experienced an anaphylactic shock. During anaphylaxis, serum tryptase was reported to reach peak levels approximately 1 h after shock in anaphylaxis cases [<xref ref-type="bibr" rid="scirp.65375-ref8">8</xref>] , which was also observed in this patient. Recent studies have demonstrated that rocuronium has a higher risk of inducing IgE-mediated anaphylaxis than other muscle relaxant agents [<xref ref-type="bibr" rid="scirp.65375-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.65375-ref10">10</xref>] . Radioimmunoassay for IgE antibodies to specific NMBAs proved to be both more sensitive and efficient [<xref ref-type="bibr" rid="scirp.65375-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.65375-ref12">12</xref>] . Although the serum level of non-specific IgE was within the normal range in this patient, we could not rule out the possibility of IgE-mediated anaphylaxis because NMBA-reactive IgE antibodies were not specifically measured. Intradermal allergen testing of rocuronium was debated in this patient, which was not performed as the test itself could induce anaphylaxis again. Further, intradermal tests were shown to produce false-positive reactions in some cases [<xref ref-type="bibr" rid="scirp.65375-ref13">13</xref>] . Numerous recent reports demonstrated that sugammadex, a selective relaxant binding agent, might be able to improve recovery in cases of anaphylaxis triggered by rocuronium [<xref ref-type="bibr" rid="scirp.65375-ref14">14</xref>] [<xref ref-type="bibr" rid="scirp.65375-ref15">15</xref>] . However, sugammadex was not used in this case because his condition improved after the administration of vasopressors and a steroid as standard treatments we provided for anaphylactic shock.</p></sec><sec id="s4"><title>4. Conclusion</title><p>In summary, we report a case of severe anaphylactic shock in a 5-month-old infant who was scheduled to undergo external inguinal hernia repair under general anesthesia. Rocuronium used during anesthesia induction was the most likely causative agent. High levels of serum tryptase and histamine supported the diagnosis of anaphylactic shock. The planned surgery was canceled, and the rescheduled surgery was successfully completed 5 months later under general anesthesia with a supraglottic airway device and in the absence of any NMBAs. This case gives us a caution that rocuronium can be a causative of severe anaphylactic shock even in infants.</p></sec><sec id="s5"><title>Acknowledgements</title><p>Authors thank the patient’s parent for their written permission to publish the case.</p></sec><sec id="s6"><title>Funding</title><p>None.</p></sec><sec id="s7"><title>Conflict of Interest</title><p>None.</p></sec><sec id="s8"><title>Cite this paper</title><p>Hideya Katoh,Yoshifumi Naito,Chihiro Aoki,Mao Kinoshita,Yoshinobu Nakayama,Teiji Sawa, (2016) Suspected Anaphylactic Shock Associated with Rocuronium in an Infant: A Case Report. Open Journal of Anesthesiology,06,51-54. doi: 10.4236/ojanes.2016.64008</p></sec><sec id="s9"><title>NOTES</title></sec></body><back><ref-list><title>References</title><ref id="scirp.65375-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Mertes, P.M. and Volcheck, G.W. (2015) Anaphylaxis to Neuromuscular-Blocking Drugs: All Neuromuscular-Blocking Drugs Are Not the Same. Anesthesiology, 122, 5-7. http://dx.doi.org/10.1097/ALN.0000000000000516</mixed-citation></ref><ref id="scirp.65375-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Mertes, P.M., Laxenaire, M.C., Alla, F. and Groupe d’Etudes des Reactions Anaphylactoides, P. (2003) Anaphylactic and Anaphylactoid Reactions Occurring during Anesthesia in France in 1999-2000. Anesthesiology, 99, 536-545. http://dx.doi.org/10.1097/00000542-200309000-00007</mixed-citation></ref><ref id="scirp.65375-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Mertes, P.M., Laxenaire, M.C., Lienhart, A., Aberer, W., Ring, J., Pichler, W.J., et al. (2005) Reducing the Risk of Anaphylaxis during Anaesthesia: Guidelines for Clinical Practice. Journal of Investigational Allergology and Clinical Immunology, 15, 91-101.</mixed-citation></ref><ref id="scirp.65375-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Laxenaire, M.C. and Mertes, P.M. (2001) Anaphylaxis during Anaesthesia. Results of a Two-Year Survey in France. British Journal of Anaesthesia, 87, 549-558. http://dx.doi.org/10.1093/bja/87.4.549</mixed-citation></ref><ref id="scirp.65375-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Choi, S.H., Yi, J.W. and Rha, Y.H. (2013) Rocuronium Anaphylaxis in a 3-Year-Old Girl with No Previous Exposure to Neuromuscular Blocking Agents. Asian Pacific Journal of Allergy and Immunology, 1, 163-166. http://dx.doi.org/10.12932/ap0256.31.2.2013</mixed-citation></ref><ref id="scirp.65375-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Sadleir, P.H., Clarke, R.C., Bunning, D.L. and Platt, P.R. (2013) Anaphylaxis to Neuromuscular Blocking Drugs: Incidence and Cross-Reactivity in Western Australia from 2002 to 2011. British Journal of Anaesthesia, 110, 981-987. http://dx.doi.org/10.1093/bja/aes506</mixed-citation></ref><ref id="scirp.65375-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Jang, Y.H., Kim, S.G., Son, Y.H. and Park, J.M. (2010) Rocuronium Bromide Induced Anaphylaxis in a Child—A Case Report. Korean Journal of Anesthesiology, 59, 411-415. http://dx.doi.org/10.4097/kjae.2010.59.6.411</mixed-citation></ref><ref id="scirp.65375-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Harper, N.J., Dixon, T., Dugue, P., Edgar, D.M., Fay, A., Gooi, H.C., et al. (2009) Suspected Anaphylactic Reactions Associated with Anaesthesia. Anaesthesia, 64, 199-211. http://dx.doi.org/10.1111/j.1365-2044.2008.05733.x</mixed-citation></ref><ref id="scirp.65375-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Sadleir, P.H., Clarke, R.C., Bunning, D.L. and Platt, P.R. (2013) Anaphylaxis to Neuromuscular Blocking Drugs: Incidence and Cross-Reactivity in Western Australia from 2002 to 2011. British Journal of Anaesthesia, 110, 981-987. http://dx.doi.org/10.1093/bja/aes506</mixed-citation></ref><ref id="scirp.65375-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Takazawa, T., Mitsuhata, H. and Mertes, P.M. (2015) Sugammadex and Rocuronium-Induced Anaphylaxis. Journal of Anesthesia, 30, 290-297. http://dx.doi.org/10.1007/s00540-015-2105-x</mixed-citation></ref><ref id="scirp.65375-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Baldo, B.A. and Fisher, M.M. (1993) Diagnosis of IgE-Dependent Anaphylaxis to Neuromuscular Blocking Drugs, Thiopentone and Opioids. Annales Fran&amp;ccedilaises d’anesthèsie et de Rèanimation, 12, 173-181. http://dx.doi.org/10.1016/S0750-7658(05)81027-5</mixed-citation></ref><ref id="scirp.65375-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Fisher, M.M. and Baldo, B.A. (2000) Immunoassays in the Diagnosis of Anaphylaxis to Neuromuscular Blocking Drugs: The Value of Morphine for the Detection of IgE Antibodies in Allergic Subjects. Anaesthesia and Intensive Care, 28, 167-170.</mixed-citation></ref><ref id="scirp.65375-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Fisher, M. and Baldo, B.A. (1994) Anaphylaxis during Anaesthesia: Current Aspects of Diagnosis and Prevention. European Journal of Anaesthesiology, 11, 263-284.</mixed-citation></ref><ref id="scirp.65375-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">McDonnell, N.J., Pavy, T.J., Green, L.K. and Platt, P.R. (2011) Sugammadex in the Management of Rocuronium-Induced Anaphylaxis. British Journal of Anaesthesia, 106, 199-201. http://dx.doi.org/10.1093/bja/aeq366</mixed-citation></ref><ref id="scirp.65375-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Raft, J., Belhadj-Tahar, N. and Meistelman, C. (2014) Slow Recovery after Sugammadex Bolus after Rocuronium-Induced Anaphylaxis. British Journal of Anaesthesia, 112, 1115-1116. http://dx.doi.org/10.1093/bja/aeu167</mixed-citation></ref></ref-list></back></article>